Real Estate Healthcare Sector

Lifecore Biomedical

Market Cap: US$255.3m

Operates as an integrated contract development and manufacturing organization in the United States.

Inozyme Pharma

Market Cap: US$255.0m

A clinical-stage biopharmaceutical company, develops therapeutics for rare diseases that affect bone health and blood vessel function.

Cerus

Market Cap: US$254.2m

Operates as a biomedical products company.

ZimVie

Market Cap: US$251.6m

Develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide.

Terns Pharmaceuticals

Market Cap: US$251.5m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Foghorn Therapeutics

Market Cap: US$246.9m

A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.

Corvus Pharmaceuticals

Market Cap: US$246.0m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

Tristel

Market Cap: UK£183.7m

Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.

Vanda Pharmaceuticals

Market Cap: US$245.2m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Monte Rosa Therapeutics

Market Cap: US$244.8m

A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.

Palvella Therapeutics

Market Cap: US$243.0m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.

Allogene Therapeutics

Market Cap: US$242.8m

A clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.

Tactile Systems Technology

Market Cap: US$241.8m

A medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.

Verano Holdings

Market Cap: CA$334.5m

Operates as a vertically integrated multi-state cannabis operator in the United States.

NervGen Pharma

Market Cap: CA$332.2m

A clinical-stage biotech company together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage.

Creative Medical Technology Holdings

Market Cap: US$237.0m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

Aquestive Therapeutics

Market Cap: US$236.4m

Operates as a pharmaceutical company in the United States and internationally.

Alpha Tau Medical

Market Cap: US$236.3m

A clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.

Gossamer Bio

Market Cap: US$236.3m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

Tvardi Therapeutics

Market Cap: US$236.2m

Operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases.

ProKidney

Market Cap: US$236.1m

A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

MaxCyte

Market Cap: UK£175.4m

A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

Atea Pharmaceuticals

Market Cap: US$234.5m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

Third Harmonic Bio

Market Cap: US$233.8m

A biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases.

Nuvectis Pharma

Market Cap: US$233.3m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Jade Biosciences

Market Cap: US$230.8m

Operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.

Cipher Pharmaceuticals

Market Cap: CA$319.7m

Operates as a specialty pharmaceutical company in Canada.

Bright Minds Biosciences

Market Cap: CA$318.6m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Acelyrin

Market Cap: US$227.1m

A clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines.

Monopar Therapeutics

Market Cap: US$227.1m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

Optima Health

Market Cap: UK£169.6m

Provides occupational health and wellbeing services for the public and private sectors in the United Kingdom.

Oncology Institute

Market Cap: US$226.5m

An oncology company, provides various medical oncology services in the United States.

Animalcare Group

Market Cap: UK£169.0m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

Astria Therapeutics

Market Cap: US$223.5m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

Ocugen

Market Cap: US$221.5m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.

MediWound

Market Cap: US$221.3m

A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.